EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 141 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2024. The put-call ratio across all filers is 5.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $18,793,000 | -30.2% | 516,949 | -23.2% | 1.23% | -22.2% |
Q4 2015 | $26,931,000 | +31.8% | 673,089 | -6.2% | 1.58% | +18.7% |
Q3 2015 | $20,435,000 | -20.1% | 717,369 | -7.6% | 1.33% | -11.3% |
Q2 2015 | $25,573,000 | +16.0% | 776,194 | +1.3% | 1.50% | +13.6% |
Q1 2015 | $22,043,000 | +5.2% | 766,424 | -0.4% | 1.32% | +1.3% |
Q4 2014 | $20,944,000 | +50.8% | 769,134 | +18.0% | 1.30% | +32.1% |
Q3 2014 | $13,892,000 | – | 651,884 | – | 0.99% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIMZ Investment Advisors, LLC | 57,300 | $3,609,000 | 1.62% |
SNYDER CAPITAL MANAGEMENT L P | 800,423 | $50,419,000 | 1.41% |
Zebra Capital Management LLC | 18,915 | $1,191,000 | 1.40% |
Hillcrest Asset Management LLC | 135,408 | $8,529,000 | 1.15% |
RICE HALL JAMES & ASSOCIATES, LLC | 407,347 | $25,659,000 | 0.91% |
PALISADE CAPITAL MANAGEMENT, LP | 602,480 | $37,950,000 | 0.86% |
EARNEST PARTNERS LLC | 2,121,544 | $133,636,000 | 0.78% |
Bridge City Capital, LLC | 36,390 | $2,292,000 | 0.78% |
Polianta Ltd | 18,800 | $1,184,000 | 0.61% |
CLARK ESTATES INC/NY | 69,000 | $4,346,000 | 0.57% |